Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicholas O. Fischer is active.

Publication


Featured researches published by Nicholas O. Fischer.


Chemical Communications | 2008

Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin

Jeffrey B.-H. Tok; Nicholas O. Fischer

An efficient and easy-to-execute single microbead SELEX approach is developed to generate high affinity ssDNA aptamers against botulinum neurotoxin.


PLOS ONE | 2008

Massively parallel interrogation of aptamer sequence, structure and function.

Nicholas O. Fischer; Jeffrey B.-H. Tok; Theodore M. Tarasow

Background Optimization of high affinity reagents is a significant bottleneck in medicine and the life sciences. The ability to synthetically create thousands of permutations of a lead high-affinity reagent and survey the properties of individual permutations in parallel could potentially relieve this bottleneck. Aptamers are single stranded oligonucleotides affinity reagents isolated by in vitro selection processes and as a class have been shown to bind a wide variety of target molecules. Methodology/Principal Findings High density DNA microarray technology was used to synthesize, in situ, arrays of approximately 3,900 aptamer sequence permutations in triplicate. These sequences were interrogated on-chip for their ability to bind the fluorescently-labeled cognate target, immunoglobulin E, resulting in the parallel execution of thousands of experiments. Fluorescence intensity at each array feature was well resolved and shown to be a function of the sequence present. The data demonstrated high intra- and inter-chip correlation between the same features as well as among the sequence triplicates within a single array. Consistent with aptamer mediated IgE binding, fluorescence intensity correlated strongly with specific aptamer sequences and the concentration of IgE applied to the array. Conclusion and Significance The massively parallel sequence-function analyses provided by this approach confirmed the importance of a consensus sequence found in all 21 of the original IgE aptamer sequences and support a common stem:loop structure as being the secondary structure underlying IgE binding. The microarray application, data and results presented illustrate an efficient, high information content approach to optimizing aptamer function. It also provides a foundation from which to better understand and manipulate this important class of high affinity biomolecules.


Journal of the American Chemical Society | 2009

Hydrogen Production by a Hyperthermophilic Membrane-Bound Hydrogenase in Water-Soluble Nanolipoprotein Particles

Sarah E. Baker; Robert C. Hopkins; Craig D. Blanchette; Vicki L. Walsworth; Rhoda A. Sumbad; Nicholas O. Fischer; Edward A. Kuhn; Matt Coleman; Brett A. Chromy; Sonia E. Létant; Paul D. Hoeprich; Michael W. W. Adams; Paul T. Henderson

Hydrogenases constitute a promising class of enzymes for ex vivo hydrogen production. Implementation of such applications is currently hindered by oxygen sensitivity and, in the case of membrane-bound hydrogenases (MBHs), poor water solubility. Nanolipoprotein particles (NLPs) formed from apolipoproteins and phospholipids offer a novel means of incorporating MBHs into a well-defined water-soluble matrix that maintains the enzymatic activity and is amenable to incorporation into more complex architectures. We report the synthesis, hydrogen-evolving activity, and physical characterization of the first MBH-NLP assembly. This may ultimately lead to the development of biomimetic hydrogen-production devices.


Bioconjugate Chemistry | 2009

Immobilization of his-tagged proteins on nickel-chelating nanolipoprotein particles

Nicholas O. Fischer; Craig D. Blanchette; Brett A. Chromy; Edward A. Kuhn; Brent W. Segelke; Michele Corzett; Graham Bench; Peter W. Mason; Paul D. Hoeprich

Nanolipoprotein particles (NLPs) are nanometer-sized, discoidal particles that self-assemble from purified apolipoprotein and phospholipid. Their size and facile functionalization suggest potential application of NLPs as platforms for the presentation and delivery of recombinant proteins. To this end, we investigated incorporation of nickel-chelating lipids into NLPs (NiNLPs) and subsequent sequestration of polyhistidine (His)-tagged proteins. From initial lipid screens for NLP formation, the two phospholipids DMPC and DOPC were identified as suitable bulk lipids for incorporation of the nickel-chelating lipid DOGS-NTA-Ni into NLPs, and NiNLPs were successfully formed with varying amounts of DOGS-NTA-Ni. NiNLPs consisting of 10% DOGS-NTA-Ni with 90% bulk lipid (either DMPC or DOPC) were thoroughly characterized by size exclusion chromatography (SEC), non-denaturing gradient gel electrophoresis (NDGGE), and atomic force microscopy (AFM). Three different His-tagged proteins were sequestered on NiNLPs in a nickel-dependent manner, and the amount of immobilized protein was contingent on the size and composition of the NiNLP.


Journal of the American Chemical Society | 2013

Colocalized delivery of adjuvant and antigen using nanolipoprotein particles enhances the immune response to recombinant antigens.

Nicholas O. Fischer; Amy Rasley; Michele Corzett; Mona H. Hwang; Paul D. Hoeprich; Craig D. Blanchette

Subunit antigen-based vaccines can provide a number of important benefits over traditional vaccine candidates, such as overall safety. However, because of the inherently low immunogenicity of these antigens, methods for colocalized delivery of antigen and immunostimulatory molecules (i.e., adjuvants) are needed. Here we report a robust nanolipoprotein particle (NLP)-based vaccine delivery platform that facilitates the codelivery of both subunit antigens and adjuvants. Ni-chelating NLPs (NiNLPs) were assembled to incorporate the amphipathic adjuvants monophosphoryl lipid A and cholesterol-modified CpG oligodeoxynucleotides, which can bind His-tagged protein antigens. Colocalization of antigen and adjuvant delivery using the NiNLP platform resulted in elevated antibody production against His-tagged influenza hemagglutinin 5 and Yersinia pestis LcrV antigens. Antibody titers in mice immunized with the adjuvanted NLPs were 5-10 times higher than those observed with coadministration formulations and nonadjuvanted NiNLPs. Colocalized delivery of adjuvant and antigen provides significantly greater immune stimulation in mice than coadministered formulations.


Bioconjugate Chemistry | 2010

Conjugation to nickel-chelating nanolipoprotein particles increases the potency and efficacy of subunit vaccines to prevent west nile encephalitis

Nicholas O. Fischer; Ernesto Infante; Tomohiro Ishikawa; Craig D. Blanchette; Nigel Bourne; Paul D. Hoeprich; Peter W. Mason

Subunit antigens are attractive candidates for vaccine development, as they are safe, cost-effective, and rapidly produced. Nevertheless, subunit antigens often need to be adjuvanted and/or formulated to produce products with acceptable potency and efficacy. Here, we describe a simple method for improving the potency and efficacy of a recombinant subunit antigen by its immobilization on nickel-chelating nanolipoprotein particles (NiNLPs). NiNLPs are membrane mimetic nanoparticles that provide a delivery and presentation platform amenable to binding any recombinant subunit immunogens featuring a polyhistidine tag. A His-tagged, soluble truncated form of the West Nile virus (WNV) envelope protein (trE-His) was immobilized on NiNLPs. Single inoculations of the NiNLP-trE-His produced superior anti-WNV immune responses and provided significantly improved protection against a live WNV challenge compared to mice inoculated with trE-His alone. These results have broad implications in vaccine development and optimization, as NiNLP technology is well-suited to many types of vaccines, providing a universal platform for enhancing the potency and efficacy of recombinant subunit immunogens.


PLOS ONE | 2012

Enhanced Cellulose Degradation Using Cellulase-Nanosphere Complexes

Craig D. Blanchette; Catherine I. Lacayo; Nicholas O. Fischer; Mona Hwang; Michael P. Thelen

Enzyme catalyzed conversion of plant biomass to sugars is an inherently inefficient process, and one of the major factors limiting economical biofuel production. This is due to the physical barrier presented by polymers in plant cell walls, including semi-crystalline cellulose, to soluble enzyme accessibility. In contrast to the enzymes currently used in industry, bacterial cellulosomes organize cellulases and other proteins in a scaffold structure, and are highly efficient in degrading cellulose. To mimic this clustered assembly of enzymes, we conjugated cellulase obtained from Trichoderma viride to polystyrene nanospheres (cellulase:NS) and tested the hydrolytic activity of this complex on cellulose substrates from purified and natural sources. Cellulase:NS and free cellulase were equally active on soluble carboxymethyl cellulose (CMC); however, the complexed enzyme displayed a higher affinity in its action on microcrystalline cellulose. Similarly, we found that the cellulase:NS complex was more efficient in degrading natural cellulose structures in the thickened walls of cultured wood cells. These results suggest that nanoparticle-bound enzymes can improve catalytic efficiency on physically intractable substrates. We discuss the potential for further enhancement of cellulose degradation by physically clustering combinations of different glycosyl hydrolase enzymes, and applications for using cellulase:NS complexes in biofuel production.


ACS Nano | 2008

Biofunctional subwavelength optical waveguides for biodetection

Donald J. Sirbuly; Nicholas O. Fischer; Shih Chieh J Huang; Alexander B. Artyukhin; Jeffrey B.-H. Tok; Olgica Bakajin; Aleksandr Noy

We report a versatile biofunctional subwavelength photonic device platform for real-time detection of biological molecules. Our devices contain lipid bilayer membranes fused onto metal oxide nanowire waveguides stretched across polymeric flow channels. The lipid bilayers incorporating target receptors are submersed in the propagating evanescent field of the optical cavity. We show that the lipid bilayers in our devices are continuous, have very high mobile fraction, and are resistant to fouling. We also demonstrate that our platform allows rapid membrane exchange. Finally, we use this device to detect the hybridization of specific DNA target sequences in solution to complementary probe DNA strands anchored to the lipid bilayer. This evanescent wave sensing architecture holds great potential for portable, all-optical detection systems.


PLOS ONE | 2014

Evaluation of Nanolipoprotein Particles (NLPs) as an In Vivo Delivery Platform

Nicholas O. Fischer; Dina Weilhammer; Alexis D. Dunkle; Cynthia B. Thomas; Mona H. Hwang; Michele Corzett; Cheri Lychak; Wasima Mayer; Salustra S. Urbin; Nicole M. Collette; Jiun Chiun Chang; Gabriela G. Loots; Amy Rasley; Craig D. Blanchette

Nanoparticles hold great promise for the delivery of therapeutics, yet limitations remain with regards to the use of these nanosystems for efficient long-lasting targeted delivery of therapeutics, including imparting functionality to the platform, in vivo stability, drug entrapment efficiency and toxicity. To begin to address these limitations, we evaluated the functionality, stability, cytotoxicity, toxicity, immunogenicity and in vivo biodistribution of nanolipoprotein particles (NLPs), which are mimetics of naturally occurring high-density lipoproteins (HDLs). We found that a wide range of molecules could be reliably conjugated to the NLP, including proteins, single-stranded DNA, and small molecules. The NLP was also found to be relatively stable in complex biological fluids and displayed no cytotoxicity in vitro at doses as high as 320 µg/ml. In addition, we observed that in vivo administration of the NLP daily for 14 consecutive days did not induce significant weight loss or result in lesions on excised organs. Furthermore, the NLPs did not display overt immunogenicity with respect to antibody generation. Finally, the biodistribution of the NLP in vivo was found to be highly dependent on the route of administration, where intranasal administration resulted in prolonged retention in the lung tissue. Although only a select number of NLP compositions were evaluated, the findings of this study suggest that the NLP platform holds promise for use as both a targeted and non-targeted in vivo delivery vehicle for a range of therapeutics.


Bioorganic & Medicinal Chemistry Letters | 2008

Sensitive and selective viral DNA detection assay via microbead-based rolling circle amplification

Eric Schopf; Nicholas O. Fischer; Y. Chen; Jeffrey B.-H. Tok

We report a sensitive and efficient magnetic bead-based assay for viral DNA identification using isothermal amplification of a reporting probe.

Collaboration


Dive into the Nicholas O. Fischer's collaboration.

Top Co-Authors

Avatar

Craig D. Blanchette

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Amy Rasley

University of North Carolina at Charlotte

View shared research outputs
Top Co-Authors

Avatar

Michele Corzett

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Paul D. Hoeprich

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Cheri Lychak

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Dina Weilhammer

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Edward A. Kuhn

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Gabriela G. Loots

Lawrence Livermore National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Matthew A. Coleman

Lawrence Livermore National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge